You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: May 17, 2025

Details for Patent: 10,792,306


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,792,306 protect, and when does it expire?

Patent 10,792,306 protects PLENVU and is included in one NDA.

This patent has sixty-nine patent family members in thirty-four countries.

Summary for Patent: 10,792,306
Title:Colonoscopy--preparation
Abstract: The invention provides a colon cleansing solution comprising: a) 300 to 2000 mmol per litre ascorbate anion provided by ascorbic acid, one or more salts of ascorbic acid, or a mixture thereof; and b) 10 to 200 g per litre polyethylene glycol. The invention also provides methods and kits associated with, or making use of the solutions. The invention also provides a method of cleansing the colon of a subject comprising: --administering to the subject an effect amount of a first cleansing solution; and then after a time interval--administering to the subject an effective amount of a second cleansing solution, wherein the two cleansing solutions are as described in the specification.
Inventor(s): Halphen; Marc (London, GB), Gruss; Hans-Jurgen (London, GB), Cox; Ian (London, GB), Cockett; Alasdair (London, GB), Stein; Peter (Amsterdam, NL), Ungar; Alex (Wigton, GB)
Assignee: NORGINE BV (Amsterdam, NL)
Application Number:16/788,527
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation; Device;
Patent landscape, scope, and claims:

United States Patent 10,792,306: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

United States Patent 10,792,306, titled "Colonoscopy—preparation," is a patent that addresses a specific aspect of medical preparation, particularly focusing on colon cleansing solutions. This analysis will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Patent Overview

Invention Description

The patent describes a colon cleansing solution designed to improve the efficacy and comfort of colonoscopy preparations. The solution includes a specific concentration of ascorbate anion, provided by ascorbic acid or its salts, along with other components such as preservative agents, flavorings, and potentially other additives like hydrogen or fruit juice[5].

Key Components

  • Ascorbate Anion: The solution contains 300 to 2000 mmol per liter of ascorbate anion, which is crucial for its cleansing properties.
  • Preservative Agents: Included to extend the shelf life of the solution.
  • Flavorings: Optional additives to improve the taste and make the solution more palatable.
  • Other Additives: Such as hydrogen or fruit juice, which may enhance the solution's effectiveness or user experience.

Claims Analysis

Independent Claims

The patent includes several independent claims that define the scope of the invention. These claims typically outline the essential features of the colon cleansing solution, such as the concentration of ascorbate anion and the presence of other components.

Dependent Claims

Dependent claims further specify the invention by adding additional limitations or features to the independent claims. For example, dependent claims might detail specific concentrations of ascorbate anion, types of preservative agents, or particular flavorings used.

Claim Scope

The scope of the claims is critical in determining the patent's breadth and what would be considered an infringement. The claims must be specific enough to define the invention but broad enough to cover variations that are essentially the same.

Patent Landscape

Prior Art

The patent landscape includes an analysis of prior art, which are existing inventions or publications that relate to the same field. For US10792306B2, prior art keywords include "cleansing solution," "ascorbic acid," "ascorbate," and "kit." This indicates that the patent builds upon existing knowledge in colon cleansing solutions but introduces a novel combination or concentration of ascorbate anion[5].

Global Dossier and International Patent Offices

To understand the global reach of this patent, one can use resources like the Global Dossier provided by the USPTO. This service allows users to see the patent family for a specific application, including related applications filed at participating IP Offices. This can help in identifying whether similar patents have been filed or granted in other countries[1].

Common Citation Document (CCD)

The CCD application consolidates prior art cited by all participating offices for the family members of a patent application. This tool is useful in visualizing the search results for the same invention produced by several offices on a single page, which can be crucial in assessing the novelty and non-obviousness of the invention[1].

Search and Examination Process

Patent Public Search

The Patent Public Search tool, which replaced legacy search tools like PubEast and PubWest, provides enhanced access to prior art. This tool can be used to search for similar patents and understand the competitive landscape[1].

Patent Examination Data System (PEDS)

The PEDS allows public users to search, view, and download bibliographic data for all publicly available patent applications. This can provide insights into the examination process and the outcomes of similar patent applications[1].

Economic and Statistical Analysis

Patent Claims Research Dataset

The USPTO's Patent Claims Research Dataset can provide detailed information on claims from US patents and applications. This dataset can help in analyzing the scope and trends of patent claims in the medical field, including those related to colon cleansing solutions[3].

Allowance Rates and Continuation Procedures

Understanding the probability of receiving a US patent and the use of continuation procedures can offer insights into the patent's strength and the challenges faced during the examination process. Studies have shown that continuation procedures, such as Requests for Continued Examination (RCEs), are common and can affect the allowance rates of patent applications[4].

Industry Expert Insights

Industry experts often highlight the importance of thorough patent searches and the need to understand the broader patent landscape. For example, experts might emphasize the use of tools like the Global Dossier and CCD to ensure that the invention is novel and non-obvious on a global scale.

Illustrative Statistics

  • Patent Allowance Rates: Studies have shown that the first-action allowance rate for utility patent applications can vary significantly. For instance, between 1996 and 2005, the first-action allowance rate ranged from about 10% to over 30% depending on the technology field[4].
  • Continuation Procedures: Approximately 31% of progenitor applications utilized at least one continuation procedure, with RCEs being the most common type[4].

Examples and Analogies

To better understand the significance of this patent, consider an analogy: just as a precise recipe is crucial for a culinary dish, the specific concentration of ascorbate anion in this colon cleansing solution is vital for its effectiveness. This precision is what sets this patent apart from prior art and makes it valuable in the medical field.

Key Takeaways

  • Novel Concentration: The patent introduces a novel concentration of ascorbate anion in colon cleansing solutions.
  • Broader Landscape: Understanding the global patent landscape through tools like Global Dossier and CCD is essential.
  • Economic Analysis: Analyzing patent claims and allowance rates can provide insights into the patent's strength and market potential.
  • Industry Insights: Experts emphasize thorough patent searches and understanding the broader patent landscape.

FAQs

What is the main innovation of US Patent 10,792,306?

The main innovation is the specific concentration of ascorbate anion (300 to 2000 mmol per liter) in a colon cleansing solution, which enhances its efficacy and user comfort.

How can I search for similar patents globally?

You can use the Global Dossier service provided by the USPTO to see related applications filed at participating IP Offices. Additionally, databases from other international intellectual property offices, such as the European Patent Office (EPO) and the World Intellectual Property Organization (WIPO), can be utilized[1].

What is the significance of the Common Citation Document (CCD)?

The CCD consolidates prior art cited by all participating offices for the family members of a patent application, allowing users to visualize search results on a single page and assess the novelty and non-obviousness of the invention[1].

How do continuation procedures affect patent allowance rates?

Continuation procedures, such as RCEs, can significantly affect patent allowance rates. For example, 19.5% of all applicants filed at least one RCE, which can extend the examination process and impact the final outcome[4].

Where can I find detailed information on patent claims and scope?

The USPTO's Patent Claims Research Dataset provides detailed information on claims from US patents and applications, including individually-parsed claims and claim-level statistics[3].

Cited Sources:

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. U.S. Patent and Trademark Office (USPTO) - USAGov: https://www.usa.gov/agencies/u-s-patent-and-trademark-office
  3. Patent Claims Research Dataset - USPTO: https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. What Is the Probability of Receiving a US Patent?: https://yjolt.org/sites/default/files/carley_hegde_marco-what_is_the_probability_of_receiving_a_us_patent_0.pdf
  5. US10792306B2 - Colonoscopy—preparation - Google Patents: https://patents.google.com/patent/US10792306B2/en

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 10,792,306

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Salix PLENVU ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate FOR SOLUTION;ORAL 209381-001 May 4, 2018 RX Yes Yes ⤷  Try for Free ⤷  Try for Free Y FOR CLEANSING OF THE COLON IN PREPARATION FOR COLONOSCOPY IN ADULTS ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 10,792,306

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom1104200.9Mar 11, 2011
United Kingdom1104202.5Mar 11, 2011
United Kingdom1114629.7Aug 23, 2011

International Family Members for US Patent 10,792,306

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 3141251 ⤷  Try for Free 122021000018 Germany ⤷  Try for Free
European Patent Office 3141251 ⤷  Try for Free 132021000000044 Italy ⤷  Try for Free
European Patent Office 3141251 ⤷  Try for Free 301099 Netherlands ⤷  Try for Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.